Even within the same insurer, employer plans differ
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved for type 2 diabetes management and chronic weight management
However, the results should not be interpreted as evidence that these medications prevent dementia, progressive cognitive decline, or psychiatric disease, because the study relied on diagnosis codes and remains vulnerable to residual confounding and misclassification
And for some, it may not be the best compound addition
The heartburn is caused by systemic drug effects on gastric emptying, not local tissue effects at the injection site
It ensures your body remains nourished even when your appetite is low